Skip to main content
SpringerLink
Log in

DSC and physico-chemical properties of a substituted pyridoquinoline and its interaction study with excipients

  • Published:
Journal of Thermal Analysis and Calorimetry Aims and scope Submit manuscript

Abstract

The 4,6-bis[2′(diethylamino)ethoxy]2,8,10-trimethylpyrido[3,2-g]quinoline (BG 637) is one of the compound from the pyrido[3,2-g] quinolines family. This compound had in vitro activity against the resistant cells and can reverse the multidrug resistance developed during the chemotherapeutic treatments.

To characterize BG 637, techniques such as differential scanning calorimetry (DSC), Fourier transform infrared spectrometer (FTIR), ultra violet spectrophotometry (UV), gas chromatography coupled with mass spectrometry (GC/MS), nuclear magnetic resonance (NMR) and X-ray powder diffraction (XRPD) were used. Several of them were also used to show the stability of the drug during various storage conditions.

DSC, FTIR and UV were used as screening techniques for assessing the compatibility of BG 637 with several commonly used pharmaceutical excipients. We compared the properties of the pure drug with those of binary mixture drug/excipient. Studied excipients were lactose monohydrate, microcrystalline cellulose, polyvinylpyrrolidone, sodium croscarmellose and magnesium stearate. Melting temperature and enthalpy of BG 637 in binary mixtures were similar to theoretical values. These results showed that BG 637 is a very stable compound and compatible with several pharmaceutical excipients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. E. Teodori, S. Dei, S. Scapecchi and F. Gualtieri, Il Farmaco, 57 (2002) 385.

    Article  CAS  Google Scholar 

  2. M. Volm and J. Mattern, Crit. Rev. Oncog., 7 (1996) 227.

    CAS  Google Scholar 

  3. P. Olliaro, Pharmacol. Ther., 89 (2001) 207.

    Article  CAS  Google Scholar 

  4. T. Tsuruo, H. Iida, S. Tsukagoshi and Y. Sakurai, Cancer Research, 41 (1981) 1967.

    CAS  Google Scholar 

  5. C. Matias, A. Mahamoud, J. Barbe, B. Pradine and J. C. Doury, Heterocycles, 43 (1996) 1621.

    Article  CAS  Google Scholar 

  6. ICH Harmonised Tripartite Guideline, Stability Testing of New Drug Substances and Products, ICH Q1A(R2). The European Agency for the Evaluation of Medicinal Products (CPMP/ICH/2736/99), 2003.

  7. R. C. Rowe, P. J. Sheskey and P. J. Weller, Handbook of Pharmaceutical Excipients, 4th Ed., Pharmaceutical Press (PhP) and American Pharmaceutical Association (APhA), London and Chicago 2003.

    Google Scholar 

  8. A. R. Gennaro, Ed., Remington’s Pharmaceutical Sciences, 18th Ed., Mack Publishing Company., Easton PA 1990.

    Google Scholar 

  9. A. E. Aboutaleb, A. M. Attia and F. S. Habib, Pharmazie, 38 (1983) 473.

    CAS  Google Scholar 

  10. H. A. Liebermann, L. Lachman and J. B. Schwartz, Pharmaceutical Dosage Forms: Tablets, 2nd Revised and Expanded Ed., 1996.

  11. O. A. Itiola and N. Pilped, Int. J. Pharm., 31 (1986) 99.

    Article  CAS  Google Scholar 

  12. S. Y. Lin, J. Pharm. Sci., 77 (1988) 229.

    Article  CAS  Google Scholar 

  13. Z. T. Chowhan, Pharm. Technol., 17 (1993) 72.

    CAS  Google Scholar 

  14. P. C. Mora, M. Cirri and P. Mura, J. Pharm. Biomed. Anal., 42 (2006) 3.

    Article  CAS  Google Scholar 

  15. A. A. Araujo, S. Storpirtis, L. P. Mercuri, F. M. Carvalho, M. dos Santos Filho and J. R. Matos, Int. J. Pharm., 260 (2003) 303.

    Article  CAS  Google Scholar 

  16. EDQM and European Directorate for the Quality of Medicines and Health Care, European Pharmacopoeia, 6th Ed., Council of Europe, Strasbourg 2008.

  17. I. I. Jivraj, L. G. Martini and C. M. Thomson, Pharm. Sci. Technol. Today, 3 (2000) 58.

    Article  CAS  Google Scholar 

  18. United States Pharmacopoeia-National Formulary, USP 30-NF 25, Rockville 2007.

  19. C. L. Winek, Drugs Pharm. Sci., 103 (2000) 59.

    CAS  Google Scholar 

  20. ICH Harmonised Tripartite Guideline, Impurities: Residual Solvents, ICH Q3C(R3). The European Agency for the Evaluation of Medicinal Products (CPMP/ICH/283/95), 1997.

  21. P. Bracconi, C. Andres, A. N’Diaye and Y. Pourcelot, Thermochim. Acta, 429 (2005) 43.

    Article  CAS  Google Scholar 

  22. P. Bracconi, C. Andres and A. N’Diaye, Int. J. Pharm., 262 (2003) 109.

    Article  CAS  Google Scholar 

  23. S. Sharpe, M. Celik, A. Newman and H. Brittain, Struct. Chem., 8 (1997) 73.

    Article  CAS  Google Scholar 

  24. P. Crowley and L. Martini, Pharm. Technol. Eur., 13 (2001), 26–28 see also 30–32, 34.

    CAS  Google Scholar 

  25. S. Byrn, R. Pfeiffer, M. Ganey, C. Hoiberg and G. Poochikian, Pharm. Res., 12 (1995) 945.

    Article  CAS  Google Scholar 

  26. H. G. Brittain, S. J. Bogdanowich, D. E. Bugay, J. DeVincentis, G. Lewen and A. W. Newman, Pharm. Res., 8 (1991) 963.

    Article  CAS  Google Scholar 

  27. ICH Harmonised Tripartite Guideline, Pharmaceutical Development, ICH Q8. The European Agency for the Evaluation of Medicinal Products (CPMP/ICH/167068/04), 2005.

  28. G. G. G. Oliveira, H. G Ferraz and J. S. R. Matos, J. Therm. Anal. Cal., 79 (2005) 267.

    Article  CAS  Google Scholar 

  29. M. Laszcz, B Kosmacinska, K. Korczak, B. Simigielska, M. Glice, W. Maruszak, A. Groman, H. Beczkowicz and L. Zelazko, J. Therm. Anal. Cal., 88 (2007) 305.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire de Pharmacie Galénique, Pharmacotechnie Industrielle, Biopharmacie et Cosmétologie, Faculté de Pharmacie, Université de la Méditerranée, 27 Boulevard Jean Moulin, 13385, Marseille Cedex 05, France

    D. Abbas, C. Orneto & P. Piccerelle

  2. Laboratoire de Chimie Analytique, Qualitologie, Nutrition; U.M.R. INSERM 476-INRA 1260, Faculté de Pharmacie, Université de la Méditerranée, 27 Boulevard Jean Moulin, 13385, Marseille Cedex 05, France

    J. Kaloustian, H. Portugal & A. Nicolay

Authors
  1. D. Abbas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Kaloustian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Orneto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Piccerelle
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Portugal
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Nicolay
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Kaloustian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abbas, D., Kaloustian, J., Orneto, C. et al. DSC and physico-chemical properties of a substituted pyridoquinoline and its interaction study with excipients. J Therm Anal Calorim 93, 353–360 (2008). https://doi.org/10.1007/s10973-008-9062-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10973-008-9062-7

Keywords

Search

Navigation